plays a critical role in water excretion through regulation of the production and action of the antidiuretic hormone arginine vasopressin (AVP). The AVP prohormone is produced in the hypothalamus, where its transcription is regulated by cAMP. Once released into the circulation, AVP stimulates antidiuresis through activation of vasopressin 2 receptors in renal principal cells. Vasopressin 2 receptor activation increases cAMP and activates PKA, which, in turn, phosphorylates aquaporin (AQP)2, triggering apical membrane accumulation, increased collecting duct permeability, and water reabsorption. We used single-minded homolog 1 (Sim1)-Cre recombinase-mediated expression of a dominant negative PKA regulatory subunit (RI␣B) to disrupt kinase activity in vivo and assess the role of PKA in fluid homeostasis. RI␣B expression gave rise to marked polydipsia and polyuria; however, neither hypothalamic Avp mRNA expression nor urinary AVP levels were attenuated, indicating a primary physiological effect on the kidney. RI␣B mice displayed a marked deficit in urinary concentrating ability and greatly reduced levels of AQP2 and phospho-AQP2. Dehydration induced Aqp2 mRNA in the kidney of both control and RI␣B-expressing mice, but AQP2 protein levels were still reduced in RI␣B-expressing mutants, and mice were unable to fully concentrate their urine and conserve water. We conclude that partial PKA inhibition in the kidney leads to posttranslational effects that reduce AQP2 protein levels and interfere with apical membrane localization. These findings demonstrate a distinct physiological role for PKA signaling in both short-and long-term regulation of AQP2 and characterize a novel mouse model of diabetes insipidus. principal cell; arginine vasopressin; cAMP; protein kinase A; aquaporin-2 IN RESPONSE to hypernatremia or hypovolemia, arginine vasopressin (AVP) is released into the circulation from the posterior pituitary and acts on renal vasopressin 2 receptors (V2Rs) to promote water reabsorption in the kidney (5). Short-term regulation occurs over a period of minutes through V2R activation, generation of cAMP, and insertion of aquaporin (AQP)2-containing endosomes into the apical plasma membrane (44). PKA phosphorylates AQP2 on Ser
IN RESPONSE to hypernatremia or hypovolemia, arginine vasopressin (AVP) is released into the circulation from the posterior pituitary and acts on renal vasopressin 2 receptors (V2Rs) to promote water reabsorption in the kidney (5). Short-term regulation occurs over a period of minutes through V2R activation, generation of cAMP, and insertion of aquaporin (AQP)2-containing endosomes into the apical plasma membrane (44) . PKA phosphorylates AQP2 on Ser 256 , an event that may be required for subsequent phosphorylation at Ser 269 by other kinases, and these events lead to insertion and retention of AQP2 into the apical membrane (23) . Long-term regulation, as seen with dehydration, occurs over the course of hours to days through increased Aqp2 mRNA levels, leading to a large increase in AQP2 protein (15, 21) . Phosphorylation of the cAMP response element (CRE)-binding protein (CREB) is thought to regulate Aqp2 mRNA levels through CREs, which have been identified in the promoter region of the Aqp2 gene (26, 37, 64) . The role of PKA in long-term regulation of AQP2 abundance, however, remains unclear as AQP2 expression and collecting duct water permeability remain high in the dehydrated state despite low levels of cAMP, pointing to potential PKA-independent regulation of AQP2 protein levels (32) . These factors highlight critical gaps in our knowledge of the regulation of AQP2 protein in the renal principal cell.
The PKA holoenzyme is a tetramer composed of a regulatory (R) subunit dimer that sequesters two catalytic (C) subunits in the absence of cAMP (39) . Upon cAMP binding, the C subunits dissociate from the holoenzyme and phosphorylate a range of diverse substrates to regulate cellular functions. To develop mouse genetic approaches that could be used to inhibit PKA in specific cell types, we cloned mutant forms of the RI␣ subunit that suppress C subunit activity even in the presence of physiological levels of cAMP (11, 56) . One of these dominant negative mutants (RI␣B) contains a single amino acid change (G324D) in the COOH-terminal cAMPbinding site (site B), a mutation that increases the K a for activation of the PKA holoenzyme ϳ100-fold (62). We generated mice in which the RI␣B mutation was introduced into one allele of the Prkar1a gene, and a loxP-flanked neomycin resistance cassette was placed between the last two exons to act as a stop signal and prevent expression of the RI␣B allele. Cre-mediated recombination removes this stop cassette and activates the dominant negative RI␣B allele in a cell type-specific pattern (25, 60) .
To analyze the role of PKA activity in fluid homeostasis in vivo, we used a transgenic mouse line expressing Cre recombinase to activate cell type-specific expression of RI␣B. The single-minded homolog 1 (Sim1)-Cre transgene (2) initiated RI␣B expression in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus as well as AQP2-expressing principal cells of the kidney. Expression of RI␣B in the hypothalamic PVN and SON did not appear to affect the transcription of Avp mRNA or release of AVP into the circulation. However, Sim1-directed inhibition of PKA activity in the kidney leads to severe polydipsia, decreased AQP2 protein levels, and a blunted response to short-and long-term V2R activation. A dramatic decrease in AQP2 expression occurred in the RI␣B-expressing kidney without alterations in Aqp2 mRNA levels, indicating a prominent role of PKA in regulating posttranslational stability of the water channel in vivo.
EXPERIMENTAL PROCEDURES
Experimental animals. The generation and genotyping of RI␣B mice have been previously described in detail (25, 60) . Dr. Brad Lowell (Beth Israel Deaconess Medical Center) kindly provided Sim1-Cre mice (2) . Mice used in this study were housed on a 12:12-h light-dark cycle and had free access to standard chow and water except as noted in the dehydration experiments. All experiments were conducted using protocols approved by the Institutional Animal Care and Use Committee of the University of Washington.
Urine collection and osmolality measurements. Urine production and osmolality were determined in mice with free access to water or after 24-h dehydration. Additionally, mice were subjected to acute water loading (10 mM glucose solution, 3% of body weight, oral gavage) and subsequent intraperitoneal injection of vehicle or the V2R agonist desmopressin (DDAVP; Ferring Pharmaceuticals). For urine collection, mice were placed in a modified metabolic chamber on a wire platform, and spontaneously voided urine was collected over the next 2-4 h. Urine osmolality was determined using a Vapro 5520 vapor pressure osmometer (Wescor).
Urine AVP and cAMP measurements. Spontaneously voided urine was collected as described above, and urine AVP levels were assessed by radioimmunoassay as per the manufacturer's instructions (ALPCO). For cAMP measurements, mice were given an intraperitoneal injection of DDAVP as described above, and urine samples were analyzed for cAMP content by ELISA (Enzo Life Sciences) as per the manufacturer's instructions.
X-gal staining and immunohistochemistry. After CO 2 euthanasia, mice were perfused transcardially with PBS followed by PBS-buffered 4% paraformaldehyde solution. Tissues were removed, postfixed for 2-4 h in PBS-paraformaldehyde, and then cryopreserved overnight in a 30% sucrose solution (wt/ vol). After being embedded in Tissue-Tek OCT compound (Sakura Finetek), 20-m cryosections were taken and processed for X-gal staining or immunohistochemistry. For X-gal staining, sections were washed with PBS and then incubated with X-gal solution (40 mg/ml X-gal stock solution in DMSO) diluted 1:40 into X-gal buffer [5 mM potassium ferricyanide (crystalline), 5 mM potassium ferricyanide trihydrate, and 2 mM magnesium chloride] at 37°C for 1 h to overnight in PBS. Sections were washed in PBS, dehydrated in 100% ethanol, and counterstained with eosin Y. Sections were mounted with Cytoseal 60 (Thermo Scientific) and imaged by light microscopy on a Nikon Eclipse E600 microscope. For immunohistochemistry, sections were washed in PBS and then incubated in blocking buffer (10% normal goat serum, 0.2% Triton X-100, and 2% BSA in PBS) for 1 h at room temperature. Primary antibodies (1:250) were diluted into blocking buffer, and sections were incubated at 4°C overnight. After being rinsed with PBS with 0.2% Triton X-100, sections were incubated for 2 h at room temperature with fluorescence-labeled secondary antibodies (Molecular Probes, 1:500). Sections were washed in PBS with 0.2% Triton X-100 and mounted with Vectashield medium for imaging on a Leica SL confocal microscope. All images were taken at the Keck Microscopy Facility (University of Washington).
Protein sample preparation and Western blot analysis. After CO 2 euthanasia, kidneys were bisected, and inner medullas were removed and dounce homogenized in RIPA buffer (150 mM sodium chloride, 10 mM sodium phosphate, 5 mM EDTA, 5 mM EGTA, 5 mM NaF, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS) supplemented with protease and phosphatase inhibitor cocktails [each 1% (vol/vol), Sigma].
After a brief sonication (Branson Sonifier), samples were cleared at 10,000 g for 10 min at 4°C, and the supernatant protein concentration was determined by a BCA assay (Pierce). Protein samples were diluted in 4ϫ NuPAGE sample buffer (Invitrogen), resolved on 12% polyacrylamide gels, and subsequently transferred to nitrocellulose membranes (Whatman). Membranes were blocked for 1 h in 5% BSA or milk in Tris-buffered saline with 0.1% Tween 20 (TBST) and incubated overnight in primary antibody. Membranes were then rinsed with TBST and incubated with horseradish peroxidaseconjugated secondary antibodies (Jackson ImmunoResearch) diluted at 1:10,000 in TBST with 5% BSA or milk. Horseradish peroxidase was detected with Supersignal West Pico chemiluminescent substrate (Pierce).
Kinase activity measurements. PKA activity was determined by phosphorylation of a PKA substrate peptide (Kemptide, LRRASLG) using [␥-P 32 ]ATP. Tissue samples were collected and dounce homogenized in kinase activity buffer (20 mM Tris, 0.1 mM EDTA, 0.5 mM EGTA, 10 mM DTT, 5 mM magnesium acetate, and 250 mM sucrose; pH 7.6 with 1% Triton-X 100) supplemented with 1 g/ml leupeptin, 3 g/ml aprotinin, and 5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF). Total enzymatic activity is expressed as picomoles of phosphate transferred (in units) per milligram of input protein. Activity measured in the presence of 4 g/ml protein kinase inhibitor (PKI) was assumed to be nonspecific and subtracted from each sample as background.
Immunoprecipitation of RiboTag-labeled polysomes from mouse tissues. Mice were euthanized by CO 2 , and hypothalami or whole kidneys were collected and immediately processed as previously described (51, 52) .
Real-time quantitative RT-PCR. Total RNA was isolated from the hypothalamus or kidney using an RNeasy RNA isolation kit (Qiagen). One-step RT-PCR was performed using the Mx3000P QPCR system and Brilliant II QRT-PCR reagent kit (Agilent). Relative amounts of transcripts from each tissue were extrapolated from a four-point standard curve (100, 10, 1, and 0.1 ng total RNA) made from a common brain or kidney sample. To ensure equivalent loading of total RNA, ␤-actin (Actb) was assessed in parallel during each RT-PCR experiment. Primer sequences for each transcript were obtained using PrimerBank (55) and are shown in Table 1 .
Primary antibodies. All antibodies were used at 1:1,000 for Western blot analysis and 1:250 -500 for immunohistochemistry. Antibodies purchased were as follows:: PKA C␣ and RI␣ subunits (mouse, BD Biosciences), PKA RII␣ (rabbit, Santa Cruz Biotechnology), ␤-actin (mouse, Sigma), AVP (rabbit, EMD Biosciences), hemagglutinin (HA; mouse, Covance), and AQP2 (rabbit, Novus Biologicals). Phospho-AQP2 (Ser 256 ) antibody was a kind gift from Dr. Mark Knepper (National Heart, Lung, and Blood Institute).
Data analysis. Statistical analyses were carried out using Prism 4.0c for the Mac OS (Graphpad Software). Data are presented as means Ϯ SE, and statistical significance was determined by one-way ANOVA between wild-type (WT),
Prkar1a
WT/RI␣B (RI␣B-OFF), and Sim1-Cre/Prkar1a
WT/RI␣B (RI␣B-ON) mice. Where appropriate, a Bonferroni's multiplecomparison test was conducted, and differences were considered significant at P Ͻ 0.05.
RESULTS
RI␣B expression directed by Sim1-Cre causes diabetes insipidus in mice. As shown in Fig. 1A , RI␣B-OFF mice express only one WT Prkar1a allele, and a loxP-flanked neomycin cassette placed between exons 10 and 11 disrupts RI␣B mutant allele (G324D) expression. The Sim1-Cre recombinase transgenic mouse line was crossed to the RI␣B line to initiate expression in Sim1-positive cell types. Sim1 is highly expressed in specific nuclei of the hypothalamus, primarily the PVN and SON (2) . Previously, it has also been demonstrated that Sim1 is expressed in peripheral tissues during early embryonic development, including cell populations that give rise to the pronephros and primitive metanephros (16, 40) . Sim1-Cre-mediated recombination removed the NEO stop cassette, allowing for the resumption of splicing between exons 10 and 11 and initiates expression of mutant RI␣B protein. The PVN is a critical regulatory site for water balance as well as energy homeostasis, receiving input from orexigenic (neuropeptide Y/agouti-related peptide) and anorexigenic (proopiomelanocortin) neurons in the arcuate nucleus (12) . Proopiomelanocortin neurons are thought to suppress feeding behavior through activation of melanocortin-4 receptors and increased cAMP generation. Phenotypic analysis of RI␣B-ON mice and littermate controls revealed no significant difference in food intake (Fig. 1C) or reproductive fat pad weight (Fig.  1D ), but RI␣B-ON mice developed a significant increase in body weight by 8 wk of age (change in body weight in male mice: 15.5% and change in body weight in female mice: 22.8%; Fig. 1E ). In contrast to the small effects of RI␣B activation on these parameters, we observed a marked increase in water consumption in male and female mice (Fig. 1F ), a phenotype that was readily apparent by 6 wk of age. In conjunction with increased fluid intake, RI␣B-ON mice displayed pronounced polyuria compared with WT and RI␣B-OFF littermates (Fig. 1G) .
Sim1-Cre directs RI␣B expression to selective regions of the hypothalamus and kidney. To follow Sim1-directed Cre recombinase activity in the hypothalamus and kidney, we crossed Sim1-Cre mice to the ROSA26 (R26R) reporter mouse line (54) . Cryosections from the brain and kidney were stained with X-gal to reveal ␤-galactosidase expression. As expected, Sim1-Cre induced reporter activation in the PVN and SON of the hypothalamus, as shown in Fig. 2A , left. ␤-Galactosidase expression was limited in the renal cortex, whereas higher expression levels were consistently observed in the outer medulla as well as subpopulations of cells interspersed throughout the inner medulla and renal papilla ( Fig. 2A, right) .
We next used the RiboTag mouse (51, 52) to identify specific cell populations in the hypothalamus and kidney that were targeted by Sim1-Cre. The RiboTag mouse has a modified exon 4 inserted into the ribosomal protein L22 (Rpl22) gene that incorporates three sequential HA epitopes into RPL22 after Cre-mediated recombination. Whole tissues were homogenized, and polyribosomes, with bound mRNAs, were immunoprecipitated with an anti-HA antibody, allowing selective enrichment of transcripts from cell types where Cre recombinase is expressed (Fig. 2B ). To ensure that both the PVN and SON were included in our analysis, an ϳ3-mm-wide coronal section was isolated using a brain matrix (Harvard Apparatus), and the tissue was trimmed dorsal to the hypothalamus and laterally on either side of the amygdala. Sim1 was enriched approximately fivefold in immunoprecipitated mRNA from both the hypothalamus and kidney (Fig. 2C ). Avp mRNA was enriched 11-fold when immunoprecipitated mRNA was compared with total input mRNA (Fig. 2C, left) , indicating that Sim1-Cre selectively targets the neurons known to produce AVP. The twofold higher enrichment of Avp mRNA compared with Sim1 mRNA was unexpected but could result if the Sim1-Cre transgene is not expressed at levels high enough to achieve recombination in all Sim1 mRNA-expressing neurons.
In the hypothalamus, Cre recombination occurred primarily in neurons since the oligodendrocyte marker 2=,3=-cyclic nucleotide 3=-phosphodiesterase was deenriched compared with input RNA (Fig. 2C, left) . In the kidney, Aqp2 mRNA was enriched approximately threefold, whereas the intercalated cell marker Slc26a4 was found to deenrich from the immunoprecipitated transcripts (Fig. 2C, right) . The limited expression of ␤-galactosidase throughout the inner medulla and renal papilla ( Fig.  2A, right) was also confirmed through deenrichment of mRNA for renal urea transporter UT-A1 (Slc14a2; Fig. 2C, right) . We conclude that Sim1-Cre initiates expression of RI␣B in both the hypothalamic neurons responsible for synthesizing AVP and in principal cells of the renal collecting duct, where AVP acts to regulate AQP2 expression and function. Since PKA inhibition in either hypothalamic AVP neurons or in kidney AQP2-expressing epithelial cells could potentially lead to the observed diabetes insipidus (DI) phenotypes, we examined the relative contribution of neural and renal expression of RI␣B in more detail. Hypothalamic expression of RI␣B does not inhibit AVP production or release. Because Avp mRNA was highly enriched in our RiboTag immunoprecipitates, we sought to determine if the DI phenotype in RI␣B-ON mice was mediated through attenuated PKA activity in AVP-expressing neurons of the PVN. We used the Sim1-Cre mouse to activate RiboTag in hypothalamic neurons and used antibodies specific for AVP or RPL22-HA. As shown in Fig. 3A , AVP and RPL22-HA were coexpressed in a subset of neurons concentrated within the PVN. Many species, in particular mice, also have additional AVP-expressing neurons scattered in accessory nuclei throughout the hypothalamus, which may be important in AVPdependent behavioral regulation (50); we identified AVP-expressing neurons that were not targeted by Sim1-Cre (Fig. 3A) . We isolated 1-mm coronal sections of the hypothalamus and took punches of the PVN to assess total kinase activity in lysates. Although RI␣B is expressed in the PVN, we were unable to detect any significant decrement in PKA activity in RI␣B-ON mice in the absence or presence of cAMP (Fig. 3B) . This is not particularly surprising since we expected that the RI␣B allele would only be expressed in a small subset of total cells in the punch. We then isolated total mRNA from the hypothalamus and analyzed Avp transcript levels using primers that target exon 1 of Avp mRNA. Avp mRNA was slightly elevated in RI␣B-ON mice with free access to water (Fig. 3C) ; however, there was no significant difference among control mice and those expressing RI␣B after 24-h dehydration (Fig.  3C) . Although there was no measureable difference in AVP peptide concentrations in urine after RI␣B activation compared with control groups with free access to water (Fig. 3D) , it is important to note that RI␣B mice produce 2.5-to 3-fold more urine, and, therefore, daily excretion of AVP in the urine is significantly increased. The 1.5-fold increase in Avp mRNA suggests a compensatory response to nephrogenic DI that could be caused by inhibition of PKA in renal principal cells. The degree of PKA inhibition in RI␣B-ON tissue is dependent on the normal level of expression of RI␣ compared with expression of RI␤, RII␣, and RII␤. Since many neurons express high levels of RI␤, it is possible that there is not sufficient RI␣B being made in AVP neurons to inhibit AVP production. Alternatively, other PKA-independent pathways are important regulators of Avp gene expression, as recently suggested (9, 20) .
Inhibition of PKA lowers total AQP2 protein levels in vivo. The lack of RI␣B inhibition of Avp mRNA or circulating AVP peptide levels suggested that the DI might be primarily due to renal defects in RI␣B-ON mice. We crossed Sim1-Cre mice to a reporter line that expresses the fluorescent tdTomato protein after Cre-mediated recombination (36) . As shown in Fig. 4A , tdTomato localizes to cells of the inner medulla that also express the principal cell-specific water channel AQP2. Expression of RI␣B is sufficient to disrupt the subapical membrane localization of AQP2 (Fig. 4B) , and Western blot analysis of inner medulla lysates revealed a significant decrease in total AQP2 protein (RI␣B-OFF: 1.02 Ϯ 0.03 vs. RI␣B-ON: 0.42 Ϯ 0.01, P Ͻ 0.001; Fig. 4C ). Interestingly, Aqp2 mRNA levels were not significantly different when total RNA from the inner medulla was analyzed by RT-PCR (RI␣B-OFF: 0.99 Ϯ 0.10 vs. RI␣B-ON: 0.82 Ϯ 0.05, P Ͼ 0.05; Fig. 4D ). Kinase activity assays confirmed that inner medulla RI␣B expression was sufficient to inhibit PKA activity in both the absence and presence of 5 M cAMP (Fig. 4E) . Despite the decrease in kinase activity, there were no detectable changes in RII␣ or C␣ subunit expression, as shown by Western blot analysis (Fig.  4F) . As expected, RI␣B-OFF mice expressed significantly less RI␣ protein due to inactivation of one Prkar1a allele (Fig. 4F) . RI␣ protein levels were increased in the inner medulla of RI␣B-ON mice, and this was expected since the RI␣B subunit will bind to the C subunit even in the presence of cAMP, and we have demonstrated that RI␣ is protected from degradation in the intact PKA holoenzyme (1) .
RI␣B expression attenuates the response to V2R activation. To assess the in vivo response of the kidney to acute V2R activation, mice expressing the activated RI␣B allele (RI␣B-ON) were water loaded by oral gavage to suppress circulating AVP levels. After 1 h, mice were then given an intraperitoneal Fig. 2 . Isolation of cell type-specific transcripts from tissues where Sim1-Cre is active. A: Sim1-Cre mice were crossed to the ROSA26R reporter mouse line, and cryosections from the hypothalamus and kidney were stained with X-gal to reveal ␤-galactosidase expression. B: schematic depicting purification of ribosome-bound mRNA through RiboTag immunoprecipitation (IP). Sim1-Cre mice were crossed to the RiboTag mouse, and the hypothalamus or kidneys were homogenized as previously described (51, 52) . Protein A/G magnetic bead/anti-hemagglutinin (HA) antibody complexes were used to immunoprecipitate polyribosomes and bound mRNAs for gene expression analysis of Sim1-positive cells in each tissue. C: representative quantitative RT-PCR analysis demonstrating enrichment of Sim1 mRNA in IPs from both the hypothalamus (left) and kidney (right). Transcripts analyzed included 2=,3=-cyclic nucleotide 3=-phosphodiesterase (Cnp), ␤-actin (Actb), Prkar1a, melanocortin-4 receptor (Mc4r), arginine vasopressin (Avp), Slc26a4, Slc14a2, ribosomal protein S18 (Rps18), and aquaporin 2 (Aqp2) (see Table 1 for details). Enrichment shown is the ratio of IP mRNA versus input mRNA from the crude tissue homogenate. injection of vehicle or the V2R agonist DDAVP (0.1 g/kg body wt), and urine was collected for 2 h. This dose of DDAVP prevents water load-induced diuresis in WT mice (48) . RI␣B-ON mice displayed significantly lower urine osmolality compared with control mice after ad libitum water consumption. However, acute water loading reduced urine osmolality to a similar level in both control and RI␣B-ON mice (Fig. 5A) . DDAVP injection increased urine osmolality in all three genotypes, but urinary concentrating ability was still significantly impaired in RI␣B-ON mice (Fig. 5A) . This was not due to a lack of activation of V2Rs since urinary cAMP excretion in response to acute DDAVP was not impaired in RI␣B-ON mice (Fig. 5B) . Localization of AQP2 in RI␣B-ON collecting ducts was partially rescued under these conditions (Fig. 5C ), and this is consistent with the increased urine osmolality seen in DDAVP-treated RI␣B-ON mice (Fig. 5A) . We next examined the levels of AQP2 and phospho-AQP2 (Ser 256 ) by Western blot analysis. Mice were water loaded and, after 1 h, received an intraperitoneal injection of vehicle or DDAVP (0.1 g/kg). Total AQP2 protein increased by almost twofold in control and RI␣B-ON mice after only 20 min of DDAVP treatment, suggesting a rapid stabilization of AQP2 protein. AQP2 phosphorylation was also induced two-to threefold by DDAVP in control and RI␣B-ON mice (Fig. 5D) . Nevertheless, total levels of AQP2 protein in RI␣B-ON kidneys remained low, explaining the deficit in urine concentrating ability. These results demonstrate that RI␣B expression interfered with AVP signaling downstream from the V2R in the kidney and led to decreased levels of AQP2 protein.
Prolonged dehydration increases total AQP2 expression in both control and RI␣B-ON mice. Long-term regulation of AQP2 protein levels is thought to depend on increased transcription of the Aqp2 gene (15) . However, recent studies have implicated PKA in the regulation of AQP2 protein stability through changes in the phosphorylation of Ser 256 and Ser 261 (41, 43) . We next determined the effect of RI␣B expression and chronic PKA inhibition on AQP2 levels after prolonged osmotic stress. We subjected control and RI␣B-ON mice to 24-h dehydration and analyzed the ability of the kidney to concentrate urine as well as the localization and expression levels of AQP2. RI␣B-ON mice displayed an improved urinary concentrating ability after 24-h dehydration (Fig. 6A ), although they were still deficient compared with WT and RI␣B-OFF control mice. We isolated total RNA from control and RI␣B-ON kidneys and analyzed mRNA content for water channels involved in urinary concentration. Total transcript levels for Aqp2 and Aqp3 were not significantly different between RI␣B-OFF and RI␣B-ON mice with ad libitum water consumption and were induced twofold by dehydration (Fig.  6B ). As expected, transcripts for the vasopressin renal-type receptor (Avp2r) and Aqp4 did not change with dehydration; similarly, they were not significantly different among the three genotypes (data not shown). After 24-h dehydration, AQP2 apical localization was partially restored in RI␣B-ON mice (Fig. 6C, top) , whereas total AQP2 protein was still reduced under these conditions (Fig. 6C, bottom) . Total AQP2 protein levels were increased approximately fivefold in WT and RI␣B-OFF kidney, suggesting that AQP2 levels are being regulated at both transcriptional and posttranscriptional levels (Fig. 6D) . Total AQP2, AQP2 phosphorylation, and urinary concentrating ability all remained deficient in RI␣B-ON kidneys under dehydration conditions, despite the normal expression and induction of Aqp2 mRNA (Fig. 6D ). As observed with acute activation of V2Rs, prolonged osmotic stress resulted in a significantly larger fold increase in AQP2 phosphorylation in RI␣B-ON mice, accounting for their sustained ability to concentrate their urine under these conditions. PKA is targeted to subcellular locations through its interaction with A-kinase anchoring proteins (AKAPs), allowing for highly specific responses to unique ligands. PKA activity has been shown to copurify with AQP2-containing vesicles (31) , and the kinase has been reported to colocalize or directly interact with AQP2 through its interaction with at least three different AKAPs (22, 28, 47) . Since the majority of AKAPs bind RII subunits of PKA with high affinity, we examined urinary concentrating ability in mice lacking either RII␣ or RII␤ regulatory subunits (7, 13) . RII␣ subunits colocalized with AQP2 in principal cells of the inner medulla (Fig. 7A) and, by Western blot analysis, we do not detect expression of RII␤ in the inner medulla (data not shown). Mice with a targeted disruption in either RII␣ or RII␤ subunits displayed no changes in urine osmolality with ad libitum water consumption, and these mice maintained their ability to concentrate Fig. 3 . Avp mRNA expression and circulating peptide levels. A: colocalization of AVP and HA after Sim1-Cre mice were crossed to the RiboTag mouse. 3V, third ventricle. B: total PKA activity in the presence or absence of 5 M cAMP (n ϭ 3 mice/group). Homogenates were prepared as described from punches that were taken from coronal sections containing paraventricular nucleus (PVN) neurons. C: total hypothalamic expression of Avp mRNA in control and RI␣B-ON mice with ad libitum water consumption or after 24-h dehydration (n ϭ 4 mice/group). *P Ͻ 0.05. D: urinary AVP levels with ad libitum water consumption, as assessed by radioimmunoassay (n ϭ 4 mice/group). their urine in response to 24-h dehydration (Fig. 7B) . These results suggest that anchoring of the type II kinase is not a specific requirement for proper function of AQP2 channels.
DISCUSSION
In the present study, we demonstrated that partial suppression of PKA activity through RI␣B expression is sufficient to disrupt fluid homeostasis and alter the localization and expression of AQP2 protein. Surprisingly, our results suggest a major posttranscriptional role for PKA in the maintenance of total AQP2 protein levels in vivo both during ad libitum water consumption and after prolonged dehydration. Sim1-Cre-mediated expression of RI␣B gave rise to a striking DI phenotype, and more detailed analysis revealed that this pathology is predominantly nephrogenic rather than neurogenic in origin.
Sim1-Cre is expressed in both the inner medulla of the kidney and the PVN/SON of the hypothalamus, where AVP is synthesized and then transported to the posterior pituitary. Using both in vivo and in vitro approaches, it has been previously demonstrated that elevated serum osmolality or exposure to hyperosmotic solutions resulted in increased cAMP levels in the SON and, to a lesser extent, in the PVN (8) . cAMP-dependent Avp transcriptional regulation may occur through PKA-mediated phosphorylation of CREB, which binds to putative CREs identified in the Avp promoter (27) . Indeed, viral overexpression of the endogenous PKA inhibitor PKI␣ blunted AVP induction in the PVN in response to dehydration (61), whereas Sim1-Cre-mediated disruption of CREB1 in the PVN reduced basal AVP protein levels (9) . In contrast, recent work has shown that a dominant negative form of CREB reduced expression of the immediate early gene c-fos but had no effect on AVP production in vivo (35) . These results suggested that Avp expression may be regulated by additional members of the ATF family of transcription factors. CREB3L1 has been recently shown to bind to the promoter region of the Avp gene and increase AVP expression in vivo (20) ; however, it is important to note that this transcription factor is activated by regulated proteolysis rather than PKAmediated phosphorylation (42) . Despite Sim1-Cre-driven reporter activity in the PVN (Figs. 2A and 3A) , we were unable to detect any inhibition of Avp mRNA or urinary AVP peptide levels (Fig. 3, C and D) that might explain the DI phenotype. representative Western blots and quantitation of total AQP2 protein levels in the inner medulla. Quantitation shows both glycosylated (Gly-AQP2) and nonglycosylated (NG-AQP2) bands. ␤-Actin was used as a loading control. n ϭ 4. ***P Ͻ 0.001. D: total Aqp2 mRNA levels in isolated inner medullas from control and RI␣B-ON mice (n ϭ 4). Actb transcript levels were used to ensure equivalent loading of RNA. E: total inner medulla PKA activity in the presence or absence of 5 M cAMP. n ϭ 4. ***P Ͻ 0.001. F: representative Western blot and quantitation of PKA regulatory and catalytic subunit expression in the inner medulla of control (WT and RI␣B-OFF) and RI␣B-ON mice. n ϭ 3. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001.
This supports the possibility that PKA-independent regulation of the Avp gene by CREB3L1 or other transcription factors may be the dominant pathway. In RI␣B-ON mice with free access to water, Avp mRNA was increased by 1.5-fold in the RI␣B-ON hypothalamus (Fig. 3C ), likely as a response to DI induced by RI␣B expression in the kidney. A threefold increase in Avp mRNA was observed in a mouse with DI caused by deletion of adenylate cyclase type 6, which is highly expressed in the kidney (49) .
Sim1-Cre-dependent activation of RI␣B in the kidney leads to a dramatic inhibition of water reabsorption. AVP regulates collecting duct water permeability through both short-and long-term mechanisms. Whereas we observed no significant change in Aqp2 mRNA, there was a 60% decrease in the level of APQ2 protein in the RI␣B-ON kidney (Fig. 4C ). This suggests a role for PKA in regulating the posttranslational stability of AQP2, and we hypothesize that this depends on PKA-dependent phosphorylation events that occur in the COOH-terminal tail of AQP2. PKA-mediated phosphorylation of Ser 256 is well accepted as a required event for apical exocytosis of AQP2-containing vesicles. Both in vitro and in vivo, Knepper and colleagues (23) demonstrated that phospho- 1 g/kg) . Urine was collected for 2 h, and osmolality was assessed as described in EXPERIMENTAL PROCEDURES. n ϭ 4. *P Ͻ 0.05; #P Ͻ 0.001. B: in response to DDAVP injection, urinary cAMP excretion was assessed by ELISA in control and RI␣B-ON mice (n ϭ 3). C: control and RI␣B-ON mice were water loaded as in A and euthanized 20 min after vehicle or DDAVP injection, and AQP2 localization was assessed by immunohistochemistry. D: additional groups of mice were treated as in C, and inner medullas were microdissected and dounce homogenized in RIPA buffer for Western blot analysis. Representative Western blots and quantitation of total AQP2 and phosphorylated (P-)AQP2 (Ser 256 ) are shown. n ϭ 3. *P Ͻ 0.05; **P Ͻ 0.01. ␤-Actin was used as a loading control.
Ser
256 is a priming site for subsequent phosphorylation at Ser 269 , a residue that regulates endocytosis of AQP2 from the apical membrane. Impaired exo-or endocytosis of AQP2 has been shown to alter the stability and half-life of the protein in AQP2-expressing cell lines. In Madin Darby canine kidney cells, loss of phosphorylation at either site has effects on the stability of AQP2 protein, as both S256A and S269A mutants exhibited reduced half-lives (41) . A potentially conflicting result emerged from the genetic analysis of a mouse line with a spontaneous mutation leading to autosomal recessive congenital progressive hydronephrosis (Cph). Cph mice carried a S256L mutation that prevented phosphorylation at that site, and mice displayed severe DI symptoms in addition to Cph.
The S256L AQP2 protein appeared to insert into the basolateral membranes, and there was an induction of both AQP2 mRNA and protein in kidneys from Cph mice (38) . Our results showing a rapid increase in AQP2 protein after only 20 min of DDAVP stimulation in water-loaded animals are in agreement with the rapid increases in AQP2 protein observed in primary cultures of rat inner medullary collecting duct cells after either AVP or forskolin addition (43) .
Phosphorylation of AQP2 alters its interactions with other proteins, including components of the actin cytoskeleton that regulate its trafficking to the apical membrane. AVP induces depolymerization of F-actin in the subapical cortex of the principal cell, a step proposed to remove the dense actin barrier Fig. 6 . Effect of 24-h dehydration on urinary concentration and AQP2 phosphorylation and trafficking. A: urine osmolality in control and RI␣B-ON mice with ad libitum water consumption or after 24-h dehydration. n ϭ 6 -8. **P Ͻ 0.01; #P Ͻ 0.001. B: quantitative RT-PCR analysis of Aqp2 and Aqp3 expression in control and RI␣B-ON mice with or without 24-h dehydration (n ϭ 4). Actb transcript levels were used as a control. C, top: control and RI␣B-ON mice were subjected to 24-h dehydration, and total AQP2 localization was assessed by immunohistochemistry. Bottom, low-magnification image of AQP2 expression in RI␣B-OFF and RI␣B-ON mice subjected to 24-h dehydration. D: representative Western blots and quantitation of total AQP2 and P-AQP2 (Ser 256 ) levels in control and RI␣B-ON mice with ad libitum water consumption or after 24-h dehydration. ␤-Actin was used as a loading control. n ϭ 3. *P Ͻ 0.05; **P Ͻ 0.01; #P Ͻ 0.001.
to the trafficking and apical exocytosis of AQP2 vesicles (53) . PKA-dependent phosphorylation of AQP2 at Ser 256 decreases its interaction with G-actin while producing a high-affinity binding site for tropomyosin-5b (TM5b) (45) . Binding to phospho-AQP2 (Ser 256 ) reduced TM5b interactions with F-actin, thereby enhancing its depolymerization and facilitating movement of AQP2 vesicles to the apical membrane. A direct effect of RI␣B expression on actin polymerization cannot be ruled out as PKA phosphorylates RhoA, causing dissociation from membrane-bound proteins, including Rho/Rac/Cdc-42-activated kinases, independent of GTP/GDP binding (59) . Similar to the interaction between phospho-AQP2 and TM5b, PKA-mediated inhibition of RhoA would favor depolymerization of F-actin. Indeed, inhibition of RhoA with Clostridium botulinum toxin C3 increased apical accumulation of AQP2 in CD8 collecting duct cells in the absence of V2R activation (58) . The delocalization of AQP2 in RI␣B-ON mice under ad libitum water consumption conditions that we observed in this study may reflect reduced actin depolymerization, through direct or indirect actions, and impairment of normal trafficking of AQP2 vesicles.
While PKA-dependent phosphorylation has been clearly implicated in the short-term regulation of AQP2, its role in long-term AQP2 regulation is not well understood, particularly in vivo. PKA has been shown to regulate AQP2 expression through phosphorylation of CREB and increased transcriptional activity of the Aqp2 promoter region (26, 37, 64) . However, our results show that Aqp2 mRNA levels remained normal in RI␣B-On mice either during free access to water (Figs. 4D and 6B ) or after 24-h dehydration (Fig. 6B) , demonstrating that Aqp2 mRNA levels are not affected by expression of the dominant negative PKA mutant in vivo. Alternative pathways have been suggested as regulators of the Aqp2 gene. Hyperosmotic culture medium is sufficient to maintain AQP2 expression in isolated, cultured collecting ducts, whereas a dominant negative form of tonicity element-binding protein [TonEBP or nuclear factor of activated T cells 5 (NFAT5)] decreased Aqp2 mRNA levels in mice with free access to water (30, 57) . Surprisingly, dominant negative TonEBP mice displayed normal Aqp2 mRNA levels when challenged with dehydration. These data suggest that Aqp2 gene transcription can be regulated by AVP-dependent but cAMP-and PKAindependent mechanisms in the dehydrated state. AVP treatment also increased intracellular Ca 2ϩ levels in isolated medullary collecting ducts (10) , and activation of calcineurin and NFATc1 increased Aqp2 mRNA levels in a collecting duct cell line (34) . Further studies will be needed to address the in vivo role of Ca 2ϩ -dependent Aqp2 transcriptional regulation in response to dehydration.
Treatments that bypass inactive V2Rs in patients with Xlinked nephrogenic DI would be an attractive therapeutic option (3) . Activation of alternative G␣ s -linked G proteincouple receptors expressed on inner medullary collecting duct cells with ligands like calcitonin (4), glucagon (63) , or ONO, a selective ligand for the EP4 subtype of the PGE 2 receptor (33), increased cAMP levels in the inner medullary collecting duct and improved water reabsorption. ONO was used to treat mice with V2R knockout induced in adulthood, and this significantly improved the DI phenotype and produced a modest increase in AQP2 protein (33) . However, none of these agonists have been shown to induce Aqp2 mRNA and may be acting primarily through short-term regulation of AQP2 phosphorylation and membrane localization. Interestingly, genetic disruption of adenylate cyclase type 6 virtually ablated the AVP-induced increase in cAMP levels in the inner medulla but had no effect on the basal level of AQP2 protein (49) . In contrast, the DI ϩ/ϩ mouse (18, 24) , which has constitutively high type IV phosphodiesterase activity and impaired cAMP accumulation in the collecting duct, displays a drastic reduction in both AQP2 mRNA and protein. It will be essential to determine the ability of drugs that can bypass the V2R to impact short-term AQP2 phosphorylation and membrane insertion, AQP2 protein stability, and the long-term transcriptional regulation of Aqp2 in the treatment of X-linked nephrogenic DI.
The PKA holoenzyme is targeted to distinct subcellular locations through its interactions with AKAPs, molecular scaffolds that serve to generate signaling specificity in response to increased intracellular cAMP levels. AKAP-mediated targeting of PKA activity is required for AQP2 translocation to the apical surface in cultured primary principal cells, and AKAP7␦ (also known as AKAP18␦) was first cloned from the rat kidney and copurified with AQP2-containing vesicles (22, 29) . While the RII regulatory subunit is not required for normal urinary concentration in mice subjected to dehydration (Fig. 7B) , these data do not preclude a role for targeted PKA activity in regulating AQP2 translocation to the apical membrane. We have previously demonstrated robust posttranslational stabilization of the RI␣ subunit in both RII␣ and RII␤ knockout mice (7, 13) ; PKA is likely still targeted to AQP2-containing vesicles through interactions of the RI holoenzyme with AKAP7 and/or AKAP11, both of which bind to the RI␣ subunit (6, 14) . It is interesting to speculate that our present findings, combined with the studies outlined above, point to an even more intricate compartmentalization of cAMP and PKA than is currently appreciated with regard to AQP2 expression and trafficking in the kidney.
Our results suggest a robust posttranscriptional role for PKA in regulating whole cell AQP2 levels in the collecting duct under both normal conditions with water freely available and after prolonged dehydration. The in vivo induction of Aqp2 mRNA in response to dehydration was only twofold, and the partial inhibition of PKA by expression of RI␣B was not sufficient to block this Aqp2 mRNA induction. However, levels of AQP2 protein were reduced dramatically in both control and dehydrated animals. Phosphorylation of AQP2 in the RI␣B-ON kidney is also inhibited, although the link between AQP2 phosphorylation and protein turnover remains unclear. Thus, the RI␣B-ON mouse represents a novel model of nephrogenic DI that may help dissect the role of PKA in the regulation of water excretion.
